{"AllianceGenome": "4053", "HGNC": "4053", "MIM": "147571", "_id": "9636", "_version": 2, "accession": {"genomic": ["AH001495.2", "AL645608.30", "CH471183.1", "CP068277.2", "NC_000001.11", "NC_060925.1", "NG_033033.2"], "protein": ["AAA36038.1", "AAA36128.1", "AAH09507.1", "AAN86983.1", "AAP35961.1", "EAW56295.1", "NP_005092.1", "P05161.5"], "rna": ["AY168648.1", "BC009507.2", "BM712238.1", "BT007297.1", "BU161226.1", "M13755.1", "NM_005101.4"], "translation": [{"protein": "AAH09507.1", "rna": "BC009507.2"}, {"protein": "AAP35961.1", "rna": "BT007297.1"}, {"protein": "AAA36038.1", "rna": "M13755.1"}, {"protein": "AAN86983.1", "rna": "AY168648.1"}, {"protein": "NP_005092.1", "rna": "NM_005101.4"}]}, "alias": ["G1P2", "IFI15", "IMD38", "IP17", "UCRP", "hUCRP"], "ensembl": {"gene": "ENSG00000187608", "protein": ["ENSP00000485313", "ENSP00000485643", "ENSP00000496832"], "transcript": ["ENST00000624652", "ENST00000624697", "ENST00000649529"], "translation": [{"protein": "ENSP00000485643", "rna": "ENST00000624697"}, {"protein": "ENSP00000485313", "rna": "ENST00000624652"}, {"protein": "ENSP00000496832", "rna": "ENST00000649529"}], "type_of_gene": "protein_coding"}, "entrezgene": "9636", "exons": [{"cdsend": 1014478, "cdsstart": 1013573, "chr": "1", "position": [[1013496, 1013576], [1013983, 1014539]], "strand": 1, "transcript": "NM_005101", "txend": 1014539, "txstart": 1013496}], "exons_hg19": [{"cdsend": 949858, "cdsstart": 948953, "chr": "1", "position": [[948876, 948956], [949363, 949919]], "strand": 1, "transcript": "NM_005101", "txend": 949919, "txstart": 948876}], "generif": [{"pubmed": 12055236, "text": "The ISG15 gene contains a unique interferon-stimulated response element that enables the binding and recruiting not only of interferon regulatory factors but also of PU.1."}, {"pubmed": 12067988, "text": "Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells."}, {"pubmed": 14976209, "text": "RA treatment of APL and other RA-responsive leukemic cells induced expression of UBE1L and ISG15 as well as intracellular ISG15 conjugates. A physical association was found between UBE1L and ISG15 in vivo."}, {"pubmed": 15670748, "text": "Quantitative-PCR and Northern analysis confirmed down-regulation of UCRP and UBE2L6 with BRCA2 knockdown, respectively."}, {"pubmed": 15684817, "text": "ISG15 is induced by camptothecin in human tumor cells"}, {"pubmed": 15917233, "text": "The three-dimensional structure of recombinant ISG15C78S was determined at 2.4-A resolution.The docking model predicts side-chain interactions that presumably define the specificity between the ubiquitin and ISG15 ligation pathways"}, {"pubmed": 16009940, "text": "ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways."}, {"pubmed": 16122702, "text": "identify Lys92 as the only ISG15 modification site in Ubc13, which is the first report about the ISG15 modification site"}, {"pubmed": 16139798, "text": "These data indicate that ISGylation targets proteins found in several fundamentally important cellular pathways and will contribute to understanding the physiologic role of interferon-induced ISG15 and ISG15 conjugation."}, {"pubmed": 16424026, "text": "results suggest that the ISG15 pathway, which is deregulated during tumorigenesis, negatively regulates the ubiquitin/proteasome pathway by interfering with protein polyubiquitination/degradation"}, {"pubmed": 16428300, "text": "isolated ISG15-modified and unmodified UbcH6 proteins, and analyzed their abilities to form thioester intermediates with ubiquitin"}, {"pubmed": 16434471, "text": "ISG15 is the critical component in IFN-mediated inhibition of HIV-1 release"}, {"pubmed": 16641915, "text": "Higher levels of ISG15 protein is associated with muscle-invasive bladder cancer"}, {"pubmed": 16884686, "text": "Four candidate target proteins were demonstrated to be ISGylated in UBE1L- and UbcH8-dependent manners"}, {"pubmed": 17069755, "text": "Efp protein could be conjugated with not only ubiquitin but also ISG15."}, {"pubmed": 17097911, "text": "review evidence of a role for ISG15 as an endogenous tumor suppressor that, when dysregulated in malignant cells, can be subverted to promote oncogenesis"}, {"pubmed": 17222803, "text": "Thus we propose that autoISGylation of EFP negatively regulates its ISG15 E3 ligase activity for 14-3-3sigma."}, {"pubmed": 17289916, "text": "ISGylation (by ISG15) of 4EHP may play an important role in cap structure-dependent translation control in immune responses."}, {"pubmed": 17653289, "text": "ISG15 is a newcomer among ubiquitin-like molecules and utilizes the conjugating but also the deconjugating machinery of its more established relative ubiquitin."}, {"pubmed": 17692280, "text": "Our results demonstrate that SARS-CoV PLpro can differentiate between ubiquitin-like modifiers sharing a common C-terminal sequence, and that the debranching activity of the PLpro is linkage type selective."}, {"pubmed": 18287095, "text": "a mechanistically novel function of ISG15 in the enhancement of the innate anti-viral response through specific inhibition of Nedd4 Ub-E3 activity"}, {"pubmed": 18305167, "text": "These data provide evidence of antiviral activity of ISG15 against Ebola virus and suggest a mechanism of action involving disruption of Nedd4 function and subsequent ubiquitination of VP40."}, {"pubmed": 18356159, "text": "N-terminal ubiquitin-like domain of ISG15 mainly functions in the ligation step and Influenza B virus NS1 protein inhibits ISGylation by competing with E3 ligases for binding to the N-terminal domain"}, {"pubmed": 18566215, "text": "These results suggest that ISG15, which interferes with proteasome-mediated repair of TOP1-DNA covalent complexes, is a potential tumor biomarker."}, {"pubmed": 18583345, "text": "Ube1L was required for transfer of ISG15 to UbcH8 and for binding of Ube1L to UbcH8"}, {"pubmed": 18597038, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18606809, "text": "nitrosylation of ISG15 enhances target protein ISGylation"}, {"pubmed": 18627608, "text": "ISG15 is overexpressed in breast carcinoma cells compared with normal breast tissue, both at the RNA and protein level"}, {"pubmed": 18953482, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19043203, "text": "expression of the ISG15 system suppresses NF-kappaB activation"}, {"pubmed": 19073728, "text": "Kinetic analysis revealed that mutation of arginine 153 to alanine (R153A) in ISG15 ablated hISG15-hUbE1L binding and transthiolation of UbcH8."}, {"pubmed": 19074853, "text": "UBE1L-ISG15 preferentially inhibits cyclin D1 in lung cancer"}, {"pubmed": 19357168, "text": "Inhibition of influenza A virus gene expression by ISG15 conjugation in human cells is sufficient to result in inhibition of virus replication at early times of infection."}, {"pubmed": 19378789, "text": "regulates immune response. (review)"}, {"pubmed": 19430494, "text": "study describes the modulation of androgen receptor expression by ISGylation components, which affects the proliferation of prostate cancer cells, thereby providing evidence for a novel function of the ISGylation system in malignant transformation"}, {"pubmed": 19656964, "text": "These results reveal a novel function for ISG15 in the regulation of the IFN-alpha pathway and its antihepatitis C effect."}, {"pubmed": 19846672, "text": "ISG15 promotes hepatitis C virus production."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19956859, "text": "ISG15 is involved in cell growth and survival of prostate cancer"}, {"pubmed": 19959962, "text": "Data demonstrated that ISG15 is one of the genes associated with intrinsic gemcitabine sensitivity."}, {"pubmed": 20035788, "text": "ISG15 over-expression in human medulloblastoma cells significantly reduced the Japanese encephalitis virus -induced cytopathic effect and inhibited virus replication by reducing the viral titers and genomes."}, {"pubmed": 20093371, "text": "NS1B protein exhibits species-specific binding; it binds human and non-human primate ISG15 but not mouse or canine ISG15"}, {"pubmed": 20133869, "text": "NS1 protein of influenza A virus (NS1A protein), an essential, multifunctional protein, is ISG15 modified in virus-infected cells."}, {"pubmed": 20157543, "text": "Upregulation of ISG15 with telomere shortening may contribute to chronic inflammatory states associated with human aging."}, {"pubmed": 20164219, "text": "Thus, there appear to be multiple levels of ISG15-induced inhibition acting at different stages of the retrovirus release process."}, {"pubmed": 20219937, "text": "The authors demonstrate that influenza B virus NS1 protein potently antagonizes human but not mouse ISGylation, a property dependent on B/NS1 binding the N-terminal domain of human but not mouse ISG15."}, {"pubmed": 20308324, "text": "This study characterizes HERC5 as a positive regulator of innate antiviral responses, and show that it sustains IRF3 activation via a novel posttranslational modification, ISG15-ylation."}, {"pubmed": 20542004, "text": "Data suggest that, in the context of an interferon-stimulated cell, newly translated viral proteins may be primary targets of ISG15."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20628624, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20639253, "text": "data indicate that the interferon stimulated gene 15, which is induced by HCV-mediated activation of the innate immune system, is a proviral factor that plays an important role in the pathogenesis of HCV."}, {"pubmed": 20946978, "text": "In addition to cellular ISGylation targets, recent reports implicate viral proteins as targets of ISG15 modification; these studies provide fresh insights into the antiviral mechanisms of ISG15.[Review]"}, {"pubmed": 21245344, "text": "Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease"}, {"pubmed": 21298066, "text": "expression of the ISG15 is elevated in A-T cells derived from various A-T patients, as well as in brain tissues derived from the ATM knockout mice and A-T patients, suggesting that ATM negatively regulates the ISG15 pathway"}, {"pubmed": 21399617, "text": "Study report that USP21 cleaves Ub polymers, and with reduced activity also targets ISG15, but is inactive against NEDD8."}, {"pubmed": 21544738, "text": "Report of nearly complete backbone (1)H(N), (15)N, (13)C', and (13)C(alpha), as well as side chain (13)C(beta), methyl (Ile-delta1, Leu, Val), amide (Asn, Gln), and indole N-H (Trp) NMR resonance assignments for the 157-residue human ISG15 protein."}, {"pubmed": 21757684, "text": "analysis of the crystal structure of human ISG15 protein in complex with influenza B virus NS1B"}, {"pubmed": 21808041, "text": "influenza B virus NS1B-N-terminal region of NS1B binding of ISG15 is responsible for the inhibition of interferon-induced ISG15 conjugation in cells"}, {"pubmed": 22093708, "text": "The E3 ligase activity of HERC5 was required for blocking HIV-1 Gag particle production and correlated with the post-translational modification of Gag with ISG15."}, {"pubmed": 22100648, "text": "Inhibition of R. conorii-induced ISG15 by RNA interference results in significant increase in the extent of rickettsial replication, whereas UBP43 knockdown yields a reciprocal inhibitory effect."}, {"pubmed": 22185919, "text": "results suggest that the aberrant activation of the ISG15 pathway confers a motile phenotype to breast cancer cells by disrupting cell architecture and stabilizing proteins involved in cell motility, invasion and metastasis"}, {"pubmed": 22706304, "text": "ISG15 as a tumor suppressor via its conjugation to a tp63 splice variant"}, {"pubmed": 22729740, "text": "TNF-alpha elicits the induction of ISG15 and ISG15 conjugates not only via the autocrine stimulation of type I interferon expression, but also through a type I interferon-independent pathway."}, {"pubmed": 22740306, "text": "ISG15, is likely to be associated with both dysgenesis and tumorigenesis and may be a potential prognostic marker for oral cancer"}, {"pubmed": 22859821, "text": "ISG15 plays an essential role as an IFN-gamma-inducing secreted molecule for optimal antimycobacterial immunity."}, {"pubmed": 23212917, "text": "ISG15 deregulates autophagy in genotoxin-treated ataxia telangiectasia cells"}, {"pubmed": 23229543, "text": "Activation of double-stranded RNA-activated protein kinase (PKR) by interferon-stimulated gene 15 (ISG15) modification down-regulates protein translation"}, {"pubmed": 23318454, "text": "Findings support the development of ISG15 conjugation inhibitors for treating breast and also other cancers expressing oncogenic Ki-Ras."}, {"pubmed": 23588721, "text": "High interferon-stimulated gene ISG-15 expression affects HCV treatment outcome in patients co-infected with HIV and HCV."}, {"pubmed": 23750257, "text": "ISG15 does not appear to play a key role in IFN-beta-mediated C2C12 myoblast cell fusion"}, {"pubmed": 24024201, "text": "Our results suggest that ISG15 overexpression could be developed into a powerful gene-therapeutic tool for treating IFN-alpha-resistant HCC."}, {"pubmed": 24056783, "text": "expression of the ISG15 and/or ISGylation system attenuates HIF-1alpha-mediated gene expression and tumorigenic growth."}, {"pubmed": 24237697, "text": "These data support the interferon-induced generation of a Tsg101- and ISG15-dependent checkpoint in the secretory pathway that compromises influenza virus release."}, {"pubmed": 24257616, "text": "ISG15 is counteracted by vaccinia virus E3 protein and controls the proinflammatory response against viral infection."}, {"pubmed": 24300530, "text": "ISG15 is a potential prognostic marker in high-grade serous carcinoma of the ovary"}, {"pubmed": 24386835, "text": "HIV-1 infection up-regulating expression of ISG15 in cell lines."}, {"pubmed": 24452380, "text": "suppression of ISG15 by siRNA sensitized A549-CUG2 cells to vesicular stomatitis virus infection."}, {"pubmed": 24768535, "text": "Results showed that ISG15 modification (ISGylation) of PCNA plays a key role in translesion DNA synthesis termination."}, {"pubmed": 24844324, "text": "Propose that Isg15-dependent degradation of p53 represents an alternative mechanism of controlling p53 protein levels, and, thus, it is an attractive pathway for drug discovery."}, {"pubmed": 25165091, "text": "The ISG15 conjugation system represents a critical innate response mechanism in cardiomyocytes to fight the battle against invading pathogens, limiting inflammatory cardiomyopathy, heart failure, and death."}, {"pubmed": 25238261, "text": "Results suggest that high ISG15 expression is an intrinsic feature of hepatocellular carcinoma and a trigger for tumorigenesis and metastasis."}, {"pubmed": 25307056, "text": "intracellular ISG15 is IFN-alpha/beta-inducible not to serve as a substrate for ISGylation-dependent antiviral immunity, but to ensure USP18-dependent regulation of IFN-alpha/beta and prevention of IFN-alpha/beta-dependent autoinflammation"}, {"pubmed": 25368022, "text": "our work demonstrates that ISG15 is a previously unrecognized support factor for CSC in the PDAC microenvironment with a key role in pathogenesis and progression."}, {"pubmed": 25429107, "text": "ISG15 conjugation marks proteins for interaction with HDAC6 and p62 upon forced stressful conditions likely as a step toward autophagic clearance"}, {"pubmed": 25749047, "text": "free ISG15 may have antitumor and immunoregulatory function in vivo in breast cancer"}, {"pubmed": 25905045, "text": "Reovirus T3D infection induced STAT-1, ISG-15, IFIT-1, Mx1, and IFIT-3 expression."}, {"pubmed": 25906440, "text": "that ISGylation of BECN1 at Lys117, as well as Lys263, Lys265, and Lys266 serve an important role in negative regulation of intracellular processes including autophagy"}, {"pubmed": 26036210, "text": "Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible protein ISG15."}, {"pubmed": 26226047, "text": "Cellular ubiquitin is a substrate of ISG15 and Lys 29 on ubiquitin is the major ISG15 acceptor site."}, {"pubmed": 26259872, "text": "These data reveal a previously uncharacterized ISG15-dependent restriction of Listeria infection, reinforcing the view that ISG15 is a key component of the innate immune response."}, {"pubmed": 26361997, "text": "The inhibitory effect of ISG15 on HCV RNA replication does not require its conjugation to substrates by HERC5."}, {"pubmed": 26560068, "text": "Data show the induction of signal transducer and activator of transcription (STAT)1 and IFN-stimulated gene 15 protein (ISG15) in Rickettsia conorii-infected human umbilical vein endothelial cells (HUVECs)."}, {"pubmed": 26563749, "text": "ISG15 is elevated in viremic HIV-1 patients and is associated with high TRAIL and IDO levels."}, {"pubmed": 26617815, "text": "ISG15 might serve as a novel prognostic biomarker in drinkers with esophageal squamous cell cancer"}, {"pubmed": 26763998, "text": "This study shows that interferon-stimulated gene 15 (ISG15) lowers Human respiratory syncytial virus growth through protein ISGylation."}, {"pubmed": 26833585, "text": "These data indicate that hepatic expression of PSMA6, which is upregulated during viral hepatitis, likely depends on TLR3 activation and, that PSMA6 affects the expression of immunoregulatory ISG15, a proviral factor in the pathogenesis of hepatitis C virus infection."}, {"pubmed": 26844778, "text": "ISG15 dysregulation may be involved in the pathogenesis of glomerular inflammation"}, {"pubmed": 26872785, "text": "The results suggest that integrin-adhesion-induced MRTF-A-SRF activation and ISG15 expression constitute a newly discovered signaling circuit that promotes cell migration and invasion."}, {"pubmed": 26919245, "text": "Our study demonstrates a protumor role of ISG15, and suggests that ISG15 is a prognostic predictor and a potential therapeutic target for nasopharyngeal carcinoma"}, {"pubmed": 27193971, "text": "The species-specific gain-of-function in antiviral immunity observed in ISG15 deficiency is explained by the requirement of ISG15 to sustain USP18 levels in humans."}, {"pubmed": 27534820, "text": "Results show that HERC5 mediates covalent ISG15 conjugation to parkin in mammalian cells and that ISG15 is conjugated to the Lys349 and Lys369 residues of parkin which increases its ubiquitin E3 ligase activity."}, {"pubmed": 27545325, "text": "DNA damage induces ISG15 conjugation to p53 and this modification markedly enhances the binding of p53 to the promoters of its target genes as well as of its own gene by promoting phosphorylation and acetylation."}, {"pubmed": 27626177, "text": "The Interferon-stimulated 15-KDa protein (ISG15) rs1921 variant and ISG15 expression are associated with HBV-related liver diseases."}, {"pubmed": 27659523, "text": "ISG15 induces cancer cell apoptosis by disrupting the NF-kappaB signaling pathway. This study highlighted a novel role of ISG15 in tumor suppression."}, {"pubmed": 27882925, "text": "ISGylation is a ubiquitin-like modification that controls exosome release. ISGylation induction decreases microvesicular body numbers and impairs exosome secretion. Specifically, ISGylation of the MVB protein TSG101 induces its aggregation and degradation, being sufficient to impair exosome secretion."}, {"pubmed": 27926780, "text": "unlike ISG15, ubiquitin and FAT10 are conjugated to a similar degree to newly translated and pre-existing proteins."}, {"pubmed": 28186990, "text": "epletion of either ISG15 or UBE2L6/UBCH8 resulted in enhanced endogenous autophagic flux."}, {"pubmed": 28202760, "text": "This paper shows that ISG15 directly regulates Human Cytomegalovirus replication and that its accumulation restricts productive virus growth."}, {"pubmed": 28204879, "text": "ISG15 expression is relatively high in SLE patients and correlates with disease activity before treatment. ISG15 expression is higher in SLE patients with lymphocytopenia before treatment."}, {"pubmed": 28287327, "text": "Mechanism of cell-intrinsic adaptation to Adams-Oliver Syndrome gene DOCK6 disruption highlights ubiquitin-like modifier ISG15 as a regulator of RHO GTPases."}, {"pubmed": 28467275, "text": "ISG15 is able to trigger IFN-gamma production and other signaling pathways suggesting it is a potential cytokine that could interact with still unknown receptors. (Review)"}, {"pubmed": 28543875, "text": "Results suggest that unconjugated ISG15 affects the functions of HCV NS5A through protein-protein interaction."}, {"pubmed": 28630501, "text": "These results demonstrate that virus-induced IFN-lambda4 potently blocks IFN-alpha signalling by inducing high protein levels of ISG15 and USP18. Moreover, the data clearly demonstrate that DAA therapy restores IFN-alpha responsiveness in HCV-infected cells."}, {"pubmed": 28724761, "text": "This report demonstrates that ISG15 induced by Hepatitis E virus replication in Huh7-S10-3 human liver cells plays an immunomodulatory role by negatively regulating type I Interferon signaling and, thus, Hepatitis E virus sensitivity to type I Interferon."}, {"pubmed": 28881486, "text": "The structures of ubiquitin-specific protease 18 (USP18) and a USP18-Interferon-stimulated 15-KDa protein (ISG15) complex indicate the molecular basis of the specificity of the protease and its interaction with the type I interferon receptor [Review]."}, {"pubmed": 28931677, "text": "findings revealed that MERS-CoV PLpro chiefly engages human ISG15 through its C-terminal domain; structure of MERS-CoV PLpro was solved to 2.4 A in complex with the C-terminal domain of hISG15; structure of MERS-CoV PLpro in complex with this domain exposed the interface between these two entities"}, {"pubmed": 29100055, "text": "Extracellular ISG15 signals cytokine secretion through the LFA-1 integrin receptor (CD11a/CD18) in natural killer cells."}, {"pubmed": 29367604, "text": "the present study demonstrates that covalent ISG15 conjugation produces a novel CHIP regulatory mode that enhances the tumor-suppressive activity of CHIP."}, {"pubmed": 29463763, "text": "Studied foot-and-mouth disease virus (FMDV) Lbpro targeting of ISG15. Show a previously undescribed mechanism by which viruses interfere with the ubiquitin and ubiquitin-like systems."}, {"pubmed": 29518394, "text": "ISG15 reduces miR-17-5p levels and thereby promotes Beclin-1-mediated autophagy"}, {"pubmed": 29555370, "text": "Protein ISG15 mediates the tumorigenesis via c-MET/Fyn/beta-catenin pathway in Esophageal squamous cell carcinoma cell lines."}, {"pubmed": 29580840, "text": "HIV-1 IIIB infection of myeloid ThP-1 cells also reduced the IFN-alpha-mediated induction of the anti-viral gene, ISG15, but not MxA, revealing a functional consequence of this HIV-1-mediated immune evasion strategy."}, {"pubmed": 29626479, "text": "IFN-gamma increases free ISG15 levels in the cytoplasm and ISGylation in the nucleus and cytoplasm, but in a manner distinct between MCF-7 and MDA-MB-231cells."}, {"pubmed": 29853735, "text": "Hepatitis E virus may promote production of IFN-alpha/beta and expression of ISG15 via ORF3 in the early stages, and increased ISG15 subsequently inhibited the production of IFN-alpha/beta."}, {"pubmed": 30213559, "text": "Data suggest that ISG15 is in the pathogenesis of cancer, which could contribute to therapeutic intervention in cancer [Review]."}, {"pubmed": 30411299, "text": "The Overexpression of CD80 and ISG15 Are Associated with the Progression and Metastasis of Breast Cancer by a Meta-Analysis Integrating Three Microarray Datasets."}, {"pubmed": 30519829, "text": "The authors have found that NS1B-NTR (nonstructural protein NS-1, influenza B virus) can interact with hISG15/hUSP18 complex and form a tertiary complex in vitro."}, {"pubmed": 30529400, "text": "Non-muscle myosin IIA is post-translationally modified by interferon-stimulated gene 15 in breast cancer cells"}, {"pubmed": 30765861, "text": "ISG15 affects cell migration by interacting with Rac1 and regulating Rac1 activity and contributes to lymphatic metastasis in oral squamous cell carcinoma"}, {"pubmed": 30771383, "text": "The current study revealed that BAG3 did not interact with ISG15, but positively regulated ISG15 expression in pancreatic ductal adenocarcinoma cancer."}, {"pubmed": 30858391, "text": "USP18 and ISG15 coordinately impact on SKP2 and cell cycle progression."}, {"pubmed": 31428903, "text": "TNF-alpha, similar to the response by IFN-beta, could directly induce expression of ISG15 and its conjugation machinery, UbE1L and UbcH8, in human lung carcinoma."}, {"pubmed": 31444947, "text": "Intrahepatic immune changes after hepatitis c virus eradication by direct-acting antiviral therapy."}, {"pubmed": 31455647, "text": "This work clarifies the function and consequences of p53 modification by ISG15 and implicates USP18 in HIV-1 infection and potentially in carcinogenesis."}, {"pubmed": 31501523, "text": "Study demonstrated that extracellular free ISG15 played an important role in maintenance of cancer stem cell-like features of pancreatic ductal adenocarcinoma (PDAC) and revealed a novel mechanism by which TRIM29 modulates ISG15 stability via CAPN3-mediated processing, and subsequently extracellular ISG15 maintains the cancer stem cell-like features of PDAC via autocrine mode of action."}, {"pubmed": 31765674, "text": "Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease."}, {"pubmed": 32020185, "text": "Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease."}, {"pubmed": 32127658, "text": "Deleting key autophagy elongation proteins induces acquirement of tumor-associated phenotypes via ISG15."}, {"pubmed": 32402279, "text": "Systemic Type I IFN Inflammation in Human ISG15 Deficiency Leads to Necrotizing Skin Lesions."}, {"pubmed": 32416603, "text": "ISG15 Acts as a Mediator of Innate Immune Response to Pseudomonas aeruginosa Infection in C57BL/6J Mouse Corneas."}, {"pubmed": 32423918, "text": "Direct Antiviral Activity of IFN-Stimulated Genes Is Responsible for Resistance to Paramyxoviruses in ISG15-Deficient Cells."}, {"pubmed": 32472071, "text": "ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity."}, {"pubmed": 32513696, "text": "RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation."}, {"pubmed": 32553163, "text": "Results establish extracellular ISG15 as a cytokine-like protein that bridges early innate and interferon-gamma-dependent immune responses, and indicate that pathogens have evolved to differentially inhibit the intracellular and extracellular functions of ISG15."}, {"pubmed": 32597933, "text": "Interferon-stimulated gene 15 accelerates replication fork progression inducing chromosomal breakage."}, {"pubmed": 32641707, "text": "ISG15 induces ESRP1 to inhibit lung adenocarcinoma progression."}, {"pubmed": 32686110, "text": "Evidence for an involvement of the ubiquitin-like modifier ISG15 in MHC class I antigen presentation."}, {"pubmed": 32738280, "text": "Interferon stimulated gene 15 promotes Zika virus replication through regulating Jak/STAT and ISGylation pathways."}, {"pubmed": 32931521, "text": "ISG15 overexpression compensates the defect of Crimean-Congo hemorrhagic fever virus polymerase bearing a protease-inactive ovarian tumor domain."}, {"pubmed": 33024031, "text": "ISG15 Connects Autophagy and IFN-gamma-Dependent Control of Toxoplasma gondii Infection in Human Cells."}, {"pubmed": 33073304, "text": "The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer."}, {"pubmed": 33203188, "text": "More than Meets the ISG15: Emerging Roles in the DNA Damage Response and Beyond."}, {"pubmed": 33214684, "text": "Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity."}, {"pubmed": 33292152, "text": "Molecular Pathways of Interferon-Stimulated Gene 15: Implications in Cancer."}, {"pubmed": 33424843, "text": "Tumor Cell-Secreted ISG15 Promotes Tumor Cell Migration and Immune Suppression by Inducing the Macrophage M2-Like Phenotype."}, {"pubmed": 33533212, "text": "[Interferon-regulating activity of the celagrip antiviral drug and its influence on formation of reactive oxygen species and expression of innate immunity genes in the follicular lymphoma patients]."}, {"pubmed": 33797839, "text": "ISG15 is downregulated by KLF12 and implicated in maintenance of cancer stem cell-like features in cisplatin-resistant ovarian cancer."}, {"pubmed": 34110168, "text": "Conformational Dynamics in the Interaction of SARS-CoV-2 Papain-like Protease with Human Interferon-Stimulated Gene 15 Protein."}, {"pubmed": 34556814, "text": "ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling."}, {"pubmed": 34599178, "text": "Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity."}, {"pubmed": 34661519, "text": "HERC5 E3 ligase mediates ISGylation of hepatitis B virus X protein to promote viral replication."}, {"pubmed": 34784198, "text": "Unraveling the Molecular Mechanism of Recognition of Human Interferon-Stimulated Gene Product 15 by Coronavirus Papain-Like Proteases: A Multiscale Simulation Study."}, {"pubmed": 34847081, "text": "Congenital deficiency reveals critical role of ISG15 in skin homeostasis."}, {"pubmed": 34851141, "text": "Roles of ESCRT Proteins ALIX and CHMP4A and Their Interplay with Interferon-Stimulated Gene 15 during Tick-Borne Flavivirus Infection."}, {"pubmed": 35159348, "text": "ISG15 and ISGylation in Human Diseases."}, {"pubmed": 35297347, "text": "Free ISG15 and Protein ISGylation Emerging in SARS-CoV-2 Infection."}, {"pubmed": 35333911, "text": "ISG15 deficiency restricts HIV-1 infection."}, {"pubmed": 35445736, "text": "Interferonstimulated gene 15 promotes progression of endometrial carcinoma and weakens antitumor immune response."}, {"pubmed": 35506701, "text": "ISG15 enhances glioma cell stemness by promoting Oct4 protein stability."}, {"pubmed": 35538543, "text": "Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification."}, {"pubmed": 36053046, "text": "ISGylation directly modifies hypoxia-inducible factor-2alpha and enhances its polysome association."}, {"pubmed": 36736853, "text": "Interferon stimulated gene 15 (ISG15) in cancer: An update."}, {"pubmed": 36771004, "text": "The Functional Roles of ISG15/ISGylation in Cancer."}, {"pubmed": 37058744, "text": "Characterization of the induction kinetics and antiviral functions of IRF1, ISG15 and ISG20 in cells infected with gammacoronavirus avian infectious bronchitis virus."}, {"pubmed": 37115698, "text": "Pressure overload induces ISG15 to facilitate adverse ventricular remodeling and promote heart failure."}, {"pubmed": 37185902, "text": "Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin."}, {"pubmed": 37245235, "text": "The role of interferon-stimulated gene 15 in the occurence and progression of cervical squamous cell carcinoma."}, {"pubmed": 37501099, "text": "ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma."}, {"pubmed": 37573184, "text": "ISG15: its roles in SARS-CoV-2 and other viral infections."}, {"pubmed": 37625543, "text": "ISG15-USP18 Dysregulation by Oxidative Stress Promotes IFN-gamma Secretion from CD8+ T Cells in Vitiligo."}, {"pubmed": 37984483, "text": "A novel homozygous Y140X mutation of ISG15 causes diverse type I interferonopathies in sibling patients with cutaneous lesions or recurrent parenchymal pneumonia."}, {"pubmed": 38115997, "text": "Case Report: ISG15 deficiency caused by novel variants in two families and effective treatment with Janus kinase inhibition."}, {"pubmed": 38184893, "text": "Evaluation of long non-coding RNAs EGOT, NRAV, NRIR and mRNAs ISG15 and IFITM3 expressions in COVID-19 patients."}, {"pubmed": 38385083, "text": "ISG15 Promotes Progression and Gemcitabine Resistance of Pancreatic Cancer Cells Through ATG7."}, {"pubmed": 38594382, "text": "Dynamic molecular network analysis of iPSC-Purkinje cells differentiation delineates roles of ISG15 in SCA1 at the earliest stage."}, {"pubmed": 39113797, "text": "ISG15 accelerates acute kidney injury and the subsequent AKI-to-CKD transition by promoting TGFbetaR1 ISGylation."}], "genomic_pos": {"chr": "1", "end": 1014540, "ensemblgene": "ENSG00000187608", "start": 1001138, "strand": 1}, "genomic_pos_hg19": {"chr": "1", "end": 949920, "start": 948803, "strand": 1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0007229", "pubmed": 29100055, "qualifier": "involved_in", "term": "integrin-mediated signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0009615", "pubmed": 33727702, "qualifier": "involved_in", "term": "response to virus"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0009615", "pubmed": 28724761, "qualifier": "involved_in", "term": "response to virus"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0016567", "qualifier": "NOT involved_in", "term": "protein ubiquitination"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0019941", "qualifier": "involved_in", "term": "modification-dependent protein catabolic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030501", "qualifier": "involved_in", "term": "positive regulation of bone mineralization"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0031397", "pubmed": 18305167, "qualifier": "involved_in", "term": "negative regulation of protein ubiquitination"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0032020", "qualifier": "involved_in", "term": "ISG15-protein conjugation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032020", "pubmed": [16122702, 16407192, 21543490, 33727702], "qualifier": "involved_in", "term": "ISG15-protein conjugation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032020", "pubmed": 22859821, "qualifier": "involved_in", "term": "ISG15-protein conjugation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032461", "pubmed": 33727702, "qualifier": "involved_in", "term": "positive regulation of protein oligomerization"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032649", "pubmed": 22859821, "qualifier": "involved_in", "term": "regulation of type II interferon production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032728", "pubmed": 33727702, "qualifier": "involved_in", "term": "positive regulation of interferon-beta production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032729", "pubmed": 29100055, "qualifier": "involved_in", "term": "positive regulation of type II interferon production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032733", "pubmed": 29100055, "qualifier": "involved_in", "term": "positive regulation of interleukin-10 production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0034340", "pubmed": 22859821, "qualifier": "involved_in", "term": "response to type I interferon"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0042742", "pubmed": 22859821, "qualifier": "involved_in", "term": "defense response to bacterium"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045071", "pubmed": 33727702, "qualifier": "involved_in", "term": "negative regulation of viral genome replication"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045071", "pubmed": 19357168, "qualifier": "involved_in", "term": "negative regulation of viral genome replication"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045087", "pubmed": 28724761, "qualifier": "involved_in", "term": "innate immune response"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045648", "qualifier": "involved_in", "term": "positive regulation of erythrocyte differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0051607", "pubmed": 33727702, "qualifier": "involved_in", "term": "defense response to virus"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0051607", "pubmed": 19357168, "qualifier": "involved_in", "term": "defense response to virus"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0060339", "pubmed": 28724761, "qualifier": "involved_in", "term": "negative regulation of type I interferon-mediated signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0070585", "pubmed": 33727702, "qualifier": "involved_in", "term": "protein localization to mitochondrion"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005576", "pubmed": 22859821, "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "IC", "gocategory": "CC", "id": "GO:0005737", "pubmed": 24257616, "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005178", "pubmed": 29100055, "qualifier": "enables", "term": "integrin binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [16189514, 16872604, 17597759, 18305167, 19270716, 20133869, 21245344, 21266548, 21808041, 25307056, 25416956, 28438633, 28931677, 30644842, 31515488, 31765674, 32296183, 32428392, 32726803, 32814053, 32845033, 33727702, 34270554, 34663977], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0031386", "qualifier": "enables", "term": "protein tag activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0031386", "pubmed": 16407192, "qualifier": "enables", "term": "protein tag activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0031625", "qualifier": "enables", "term": "ubiquitin protein ligase binding"}]}, "homologene": {"genes": [[9544, 700141], [9598, 100609237], [9606, 9636], [9615, 100855667], [9913, 281871], [10090, 100038882], [10116, 298693]], "id": 48326}, "interpro": [{"desc": "Ubiquitin-like domain", "id": "IPR000626", "short_desc": "Ubiquitin-like_dom"}, {"desc": "Ubiquilin", "id": "IPR015496", "short_desc": "Ubiquilin"}, {"desc": "Ubiquitin domain", "id": "IPR019956", "short_desc": "Ubiquitin_dom"}, {"desc": "Ubiquitin-like domain superfamily", "id": "IPR029071", "short_desc": "Ubiquitin-like_domsf"}], "ipi": "IPI00375631", "map_location": "1p36.33", "name": "ISG15 ubiquitin like modifier", "other_names": ["interferon, alpha-inducible protein (clone IFI-15K)", "interferon-induced 17-kDa/15-kDa protein", "interferon-stimulated protein, 15 kDa", "ubiquitin cross-reactive protein", "ubiquitin-like protein ISG15"], "pantherdb": {"HGNC": "4053", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1855694", "ortholog_type": "LDO", "panther_family": "PTHR10666", "taxid": 10090, "uniprot_kb": "Q64339"}, {"RGD": "1310312", "ortholog_type": "LDO", "panther_family": "PTHR10666", "taxid": 10116, "uniprot_kb": "D4A3X3"}, {"WormBase": "WBGene00018659", "ortholog_type": "LDO", "panther_family": "PTHR10666", "taxid": 6239, "uniprot_kb": "O44821"}, {"dictyBase": "DDB_G0282441", "ortholog_type": "LDO", "panther_family": "PTHR10666", "taxid": 352472, "uniprot_kb": "Q54SI8"}, {"TAIR": "505006295", "ortholog_type": "LDO", "panther_family": "PTHR10666", "taxid": 3702, "uniprot_kb": "Q8RUC6"}], "uniprot_kb": "P05161"}, "pathway": {"kegg": [{"id": "hsa04622", "name": "RIG-I-like receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa05165", "name": "Human papillomavirus infection - Homo sapiens (human)"}, {"id": "hsa05169", "name": "Epstein-Barr virus infection - Homo sapiens (human)"}, {"id": "hsa05171", "name": "Coronavirus disease - COVID-19 - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-110313", "name": "Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template"}, {"id": "R-HSA-1169408", "name": "ISG15 antiviral mechanism"}, {"id": "R-HSA-1169410", "name": "Antiviral mechanism by IFN-stimulated genes"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-168249", "name": "Innate Immune System"}, {"id": "R-HSA-168255", "name": "Influenza Infection"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-168276", "name": "NS1 Mediated Effects on Host Pathways"}, {"id": "R-HSA-168928", "name": "DDX58/IFIH1-mediated induction of interferon-alpha/beta"}, {"id": "R-HSA-5656169", "name": "Termination of translesion DNA synthesis"}, {"id": "R-HSA-5663205", "name": "Infectious disease"}, {"id": "R-HSA-73893", "name": "DNA Damage Bypass"}, {"id": "R-HSA-73894", "name": "DNA Repair"}, {"id": "R-HSA-909733", "name": "Interferon alpha/beta signaling"}, {"id": "R-HSA-913531", "name": "Interferon Signaling"}, {"id": "R-HSA-936440", "name": "Negative regulators of DDX58/IFIH1 signaling"}, {"id": "R-HSA-9679506", "name": "SARS-CoV Infections"}, {"id": "R-HSA-9694516", "name": "SARS-CoV-2 Infection"}, {"id": "R-HSA-9705671", "name": "SARS-CoV-2 activates/modulates innate and adaptive immune responses"}, {"id": "R-HSA-9705683", "name": "SARS-CoV-2-host interactions"}, {"id": "R-HSA-9820952", "name": "Respiratory Syncytial Virus Infection Pathway"}, {"id": "R-HSA-9824446", "name": "Viral Infection Pathways"}, {"id": "R-HSA-9833110", "name": "RSV-host interactions"}, {"id": "R-HSA-9833482", "name": "PKR-mediated signaling"}], "wikipathways": [{"id": "WP3865", "name": "Novel intracellular components of RIG-I-like receptor (RLR) pathway"}, {"id": "WP4341", "name": "Non-genomic actions of 1,25 dihydroxyvitamin D3"}, {"id": "WP4655", "name": "Cytosolic DNA-sensing pathway"}, {"id": "WP4963", "name": "p53 transcriptional gene network"}, {"id": "WP619", "name": "Type II interferon signaling (IFNG)"}]}, "pdb": ["1Z2M", "2HJ8", "3PHX", "3PSE", "3R66", "3RT3", "3SDL", "5TL6", "5W8T", "5W8U", "6BI8", "6FFA", "6XA9", "7RBS", "7S6P", "8OIF", "8SE9", "8SEA", "8SEB", "8SV8"], "pfam": "PF00240", "pharmgkb": "PA28465", "pharos": {"target_id": 19483, "tdl": "Tbio"}, "pir": "A28304", "prosite": "PS50053", "reagent": {"CondMedia_CM_LibrAB": {"id": "GNF292548", "relationship": "is"}, "GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF260479", "relationship": "is"}, {"id": "GNF260480", "relationship": "is"}, {"id": "GNF260481", "relationship": "is"}, {"id": "GNF260482", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF158347", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF032001", "relationship": "similar to"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF084915", "relationship": "is"}, {"id": "GNF084916", "relationship": "is"}, {"id": "GNF084917", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054361", "relationship": "is"}, {"id": "GNF059140", "relationship": "is"}, {"id": "GNF074487", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF063885", "relationship": "is"}, {"id": "GNF063886", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF005596", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF336655", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF098409", "relationship": "is"}, {"id": "GNF138064", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_033033.2"], "protein": "NP_005092.1", "rna": "NM_005101.4", "translation": {"protein": "NP_005092.1", "rna": "NM_005101.4"}}, "reporter": {"HG-U133_Plus_2": "205483_s_at", "HG-U95Av2": ["1107_s_at", "38432_at"], "HTA-2_0": "TC01000023.hg.1", "HuEx-1_0": "4053534", "HuGene-1_1": "7896817", "HuGene-2_1": "16657594"}, "retired": [2536, 82830, 93470, 113257], "summary": "The protein encoded by this gene is a ubiquitin-like protein that is conjugated to intracellular target proteins upon activation by interferon-alpha and interferon-beta. Several functions have been ascribed to the encoded protein, including chemotactic activity towards neutrophils, direction of ligated target proteins to intermediate filaments, cell-to-cell signaling, and antiviral activity during viral infections. While conjugates of this protein have been found to be noncovalently attached to intermediate filaments, this protein is sometimes secreted. [provided by RefSeq, Dec 2012].", "symbol": "ISG15", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1825621"}, "unigene": "Hs.458485", "uniprot": {"Swiss-Prot": "P05161", "TrEMBL": ["A0A096LPJ4", "A0A096LNZ9"]}, "wikipedia": {"url_stub": "ISG15"}}